IBX
Price sensitive
IBX's IND Application Lodged with FDA for HER2 Phase 2 Trial
Imagion Biosystems Ltd
No summary is available for this announcement — open the PDF to read it in full.
Sign in for more about this company, including guidance changes and other insights.
Sign in